BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 3889937)

  • 1. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 2. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V
    J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating unconventional therapies.
    Hajto T; Saller R
    CMAJ; 1998 Oct; 159(7):759; author reply 759, 761. PubMed ID: 9805018
    [No Abstract]   [Full Text] [Related]  

  • 4. Mistletoe lectins: telomerase inhibitors in alternative cancer therapy.
    Li SS
    Drug Discov Today; 2002 Sep; 7(17):896-7. PubMed ID: 12546929
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
    Mengs U; Witthohn K; Schwarz T; Lentzen H
    Wien Med Wochenschr; 1999; 149(8-10):262-4. PubMed ID: 10483695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
    Gabius S; Gabius HJ
    Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
    [No Abstract]   [Full Text] [Related]  

  • 8. Mistletoe or not mistletoe is still the question.
    Kiene H; Büschel G; Hornebar M
    Forsch Komplementarmed Klass Naturheilkd; 2001 Oct; 8(5):309-12. PubMed ID: 11760713
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystallization of the ribosome inactivating protein ML1 from Viscum album (mistletoe) complexed with beta-D-galactose.
    Sweeney EC; Palmer RA; Pfüller U
    J Mol Biol; 1993 Dec; 234(4):1279-81. PubMed ID: 8263931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
    Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
    Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
    Friess H; Beger HG; Kunz J; Funk N; Schilling M; Büchler MW
    Anticancer Res; 1996; 16(2):915-20. PubMed ID: 8687151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mistletoe in the treatment of cancer].
    Bruseth S; Enge A
    Tidsskr Nor Laegeforen; 1993 Mar; 113(9):1058-60. PubMed ID: 8493669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin I.
    Edlund U; Hensel A; Fröse D; Pfüller U; Scheffler A
    Arzneimittelforschung; 2000 Jul; 50(7):645-51. PubMed ID: 10965423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
    Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(4B):2925-8. PubMed ID: 10652574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structure and molecular modeling of mistletoe lectin I from Viscum album.
    Eschenburg S; Krauspenhaar R; Mikhailov A; Stoeva S; Betzel C; Voelter W
    Biochem Biophys Res Commun; 1998 Jun; 247(2):367-72. PubMed ID: 9642133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mistletoe myth--claims, reality and provable perspectives].
    Gabius HJ; André S; Kaltner H; Siebert HC; von der Lieth CW; Gabius S
    Z Arztl Fortbild (Jena); 1996 Apr; 90(2):103-10. PubMed ID: 8686332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of toxic lectins from Viscum album L., ML I and ML III, to human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(6B):5095-9. PubMed ID: 10697516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A; Schietzel M
    Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
    Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.